{
    "clinical_study": {
        "@rank": "6744", 
        "arm_group": [
            {
                "arm_group_label": "1", 
                "arm_group_type": "Experimental", 
                "description": "15/30 mg d-amphetamine"
            }, 
            {
                "arm_group_label": "2", 
                "arm_group_type": "Experimental", 
                "description": "30/60 mg d-amphetamine"
            }, 
            {
                "arm_group_label": "3", 
                "arm_group_type": "Experimental", 
                "description": "placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an\n      adjunct in cocaine treatment; an evaluation of the \"\"replacement\"\" strategy."
        }, 
        "brief_title": "Dextroamphetamine as an Adjunct in Cocaine Treatment - 1", 
        "completion_date": {
            "#text": "August 2001", 
            "@type": "Actual"
        }, 
        "condition": [
            "Cocaine-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cocaine-Related Disorders", 
                "Substance-Related Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000304", 
            "org_study_id": "NIDA-09262-1", 
            "secondary_id": "P50-09262-1"
        }, 
        "intervention": [
            {
                "arm_group_label": "1", 
                "description": "15 mg for first 8 weeks and 30 mg for 2nd 8 weeks", 
                "intervention_name": "Dextroamphetamine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "2", 
                "description": "30 mg for the first 8 weeks and 60 for the second 8 weeks (16 weeks total)", 
                "intervention_name": "D-Amphetamine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "3", 
                "description": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Amphetamine", 
                "Dextroamphetamine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 14, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "Houston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77225"
                }, 
                "name": "University of Texas Health Science Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Dextroamphetamine as an Adjunct in Cocaine Treatment", 
        "overall_official": {
            "affiliation": "University of Texas", 
            "last_name": "John Grabowski, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2001", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "verifiable cocaine abstinence", 
            "safety_issue": "No", 
            "time_frame": "16 weeks of study"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000304"
        }, 
        "responsible_party": {
            "name_title": "F.Gerard Moeller", 
            "organization": "University of Texas Medical School at Houston"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Texas", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "August 1997", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2008"
    }, 
    "geocoordinates": {
        "University of Texas Health Science Center": "29.76 -95.369"
    }
}